Evaluating the newly approved Moderna mRNA flu vaccine

Following regulatory approval, scientists look at whether Moderna's mRNA flu shot will offer better efficacy and faster manufacturing adaptation compared to traditional seasonal vaccines.

• Moderna's mRNA flu vaccine has been newly approved.
• The vaccine could allow manufacturers to respond more rapidly to changing influenza strains.